You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

 

1153 Results
Blog post
A quick glance at cancer statistics can be quite sobering: Nearly one out of every two people in Ontario will develop cancer in their lifetime, and...
Jun 2019
Document
Jun 2019
Document
Jun 2019
Drug
Other Name(s): Folotyn®
Quick Link(s):
Drug Monograph, Patient Info Sheet
Dec 2021
Document
Jun 2019
Document
Jul 2019
Regimen
Cancer Type:
Skin, 
Melanoma
Show More Show more tags
, Show Less Show fewer tags
Intent: Adjuvant
Funding:
New Drug Funding Program
    Pembrolizumab (Adult and Pediatric) - Adjuvant Treatment for Completely Resected Stage IIB or IIC Melanoma
New Drug Funding Program
    Pembrolizumab - (Neo)adjuvant Treatment for Completely Resectable Stage III or IV Melanoma
Show More Show more tags
, Show Less Show fewer tags
Drugs Used:
pembrolizumab
... Show more tags
, Collapse Show fewer tags
Quick Link(s):
Regimen Monograph
Sep 2025
Document
Jul 2019

Pages